VAIKUNTHA

Quantum Biology Digital Twin

A perfect digital mirror of every patient — modeled at quantum resolution. The body simulated, before the body is treated.

VitaPharma

Partner with Us See the platform

WHAT IT IS

A new sovereign capability.

VAIKUNTHA renders each research participant as a quantum-resolution digital twin. Therapeutics, diagnostics-research workflows, and genomic interpretation run against the twin first — and only the most promising candidates survive to the wet lab.

Integrated in-silico quantum platform for therapeutics, diagnostics-research, and genomics — a digital mirror of human biology.

STRENGTHENS THE SOVEREIGN VERTICALS

How VAIKUNTHA compounds the platform.

Vita

Longevity Research Cloud

Becomes Vita's research substrate — the digital body on which longevity interventions are scored, ranked, and de-risked.

Pharma

AI Drug Discovery Sovereignty

Powers Pharma's virtual-trial layer with biology-grounded twins, compressing pre-clinical exploration into computational time.

RIDES ON THE ONE PLATFORM

Built on the GAMIE intelligence core.

Reads from the GAMIE knowledge graph, writes back twin-derived hypotheses, and exposes simulation endpoints to Vita and Pharma workflows.

Engines powering VAIKUNTHA

MEDHxBERT
MEDHxAKAZE
MEDHxLLamaXOpenHathi
MEDHxRESTNET50

Read the platform architecture

CAPABILITIES

What ships inside VAIKUNTHA.

Multi-scale digital twin

Molecular, cellular, tissue, and physiological layers cohered into a single simulatable representation.

In-silico therapeutic trials

Run drug, dose, and combination experiments against the twin before any wet-lab commitment.

Quantum-resolution genomics

Variant-pathway-phenotype reasoning at quantum-assisted resolution for rare-disease and longevity research.

Diagnostics-research orchestration

Companion-research workflows that link diagnostics signal to twin-state for hypothesis refinement.

Sovereign twin custody

Every twin lives, trains, and reasons inside the sovereign perimeter. Twin export requires sovereign-grade consent.

STRATEGIC IMPACT

Sovereign-relevant by design.

Sovereign research programs collapse the wet-lab discovery cycle, retain twin-IP inside national borders, and unlock individualized longevity research at population scale.

Customer profiles

01Sovereign longevity research clouds
02National pharma champions
03Tier-1 hospital research arms
04Sovereign genomics initiatives

DEVELOPMENT STATUS

In active research and development.

Sovereign design partners are being onboarded selectively. Reach out to align on capability fit and deployment cadence.

In development

PARTNER WITH MEDHINI

Co-develop VAIKUNTHA as a sovereign asset.

Reach the VAIKUNTHA program